Cormorant Asset Management
$2.0B Assets Reported
49 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 885,500 | $285M | 14.3% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $160M | 8.0% |
| EYPT | EYEPOINT INC | 8,265,000 | $107M | 5.4% |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,260,000 | $103M | 5.2% |
| ERAS | ERASCA INC | 5,800,000 | $94M | 4.7% |
| RAPP | RAPPORT THERAPEUTICS INC | 2,957,521 | $93M | 4.6% |
| ALMS | ALUMIS INC | 3,949,241 | $87M | 4.4% |
| ABVX | ABIVAX SA | 760,000 | $85M | 4.3% |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4,480,433 | $84M | 4.2% |
| DNTH | DIANTHUS THERAPEUTICS INC | 950,000 | $80M | 4.0% |
Track Cormorant Asset Management's 13F portfolio: $2.0B in reported holdings, 49 positions. Top holdings, AUM, and quarterly changes on SentiSense.